MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,288,202 | -42.0% | 142,656 | -16.2% | 0.00% | -50.0% |
Q2 2023 | $3,945,143 | -7.7% | 170,196 | -7.5% | 0.00% | -33.3% |
Q1 2023 | $4,274,877 | +154674.7% | 184,024 | -3.3% | 0.00% | +50.0% |
Q4 2022 | $2,762 | -99.9% | 190,383 | +51.0% | 0.00% | 0.0% |
Q3 2022 | $2,406,000 | +84.2% | 126,107 | +75.5% | 0.00% | +100.0% |
Q2 2022 | $1,306,000 | -27.6% | 71,857 | +0.5% | 0.00% | 0.0% |
Q1 2022 | $1,803,000 | -24.2% | 71,529 | -17.0% | 0.00% | 0.0% |
Q4 2021 | $2,380,000 | +25.4% | 86,231 | +46.7% | 0.00% | 0.0% |
Q3 2021 | $1,898,000 | +15.5% | 58,767 | +9.3% | 0.00% | 0.0% |
Q2 2021 | $1,644,000 | -0.2% | 53,754 | -0.6% | 0.00% | 0.0% |
Q1 2021 | $1,647,000 | +57.0% | 54,078 | +1.9% | 0.00% | 0.0% |
Q4 2020 | $1,049,000 | +61.6% | 53,054 | +6.5% | 0.00% | 0.0% |
Q3 2020 | $649,000 | -7.3% | 49,799 | -19.3% | 0.00% | 0.0% |
Q2 2020 | $700,000 | -20.6% | 61,706 | +0.1% | 0.00% | 0.0% |
Q1 2020 | $882,000 | -47.5% | 61,669 | +0.0% | 0.00% | -50.0% |
Q4 2019 | $1,679,000 | -67.6% | 61,651 | -66.0% | 0.00% | -66.7% |
Q3 2019 | $5,186,000 | +35.3% | 181,155 | +31.3% | 0.01% | +50.0% |
Q2 2019 | $3,832,000 | -53.2% | 137,930 | -47.6% | 0.00% | -20.0% |
Q1 2019 | $8,187,000 | +112.7% | 263,087 | +98.7% | 0.01% | 0.0% |
Q4 2018 | $3,849,000 | -34.8% | 132,412 | +3.2% | 0.01% | -28.6% |
Q3 2018 | $5,900,000 | +33.7% | 128,271 | +8.6% | 0.01% | +16.7% |
Q2 2018 | $4,413,000 | +31.8% | 118,086 | +4.2% | 0.01% | +50.0% |
Q1 2018 | $3,348,000 | -19.0% | 113,289 | -5.8% | 0.00% | -20.0% |
Q4 2017 | $4,132,000 | -5.1% | 120,312 | 0.0% | 0.01% | -16.7% |
Q3 2017 | $4,353,000 | +176.0% | 120,312 | +97.2% | 0.01% | +200.0% |
Q2 2017 | $1,577,000 | +34.7% | 61,011 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,171,000 | +17.6% | 61,011 | +2.1% | 0.00% | 0.0% |
Q4 2016 | $996,000 | -47.6% | 59,731 | -35.3% | 0.00% | -33.3% |
Q3 2016 | $1,901,000 | -35.7% | 92,381 | +0.2% | 0.00% | -40.0% |
Q2 2016 | $2,957,000 | -15.4% | 92,236 | +2.7% | 0.01% | -28.6% |
Q1 2016 | $3,496,000 | -9.8% | 89,783 | +0.0% | 0.01% | 0.0% |
Q4 2015 | $3,875,000 | +15.2% | 89,775 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $3,365,000 | +12.4% | 89,775 | +2.0% | 0.01% | +16.7% |
Q2 2015 | $2,993,000 | -4.0% | 88,050 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $3,117,000 | +3.6% | 88,050 | -0.3% | 0.01% | 0.0% |
Q4 2014 | $3,009,000 | – | 88,333 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |